Harvesting the Fruits of Plant Genomics

Harvesting the Fruits of Plant Genomics Pioneer Hi-Bred President Richard McConnell explains how geneticists are revolutionizing crops, yields — even the humble corn chip




Click here for reuse options!
Copyright 2002 Biotechblog

Pa. uses tobacco settlement to fund biotech

Pa. uses tobacco settlement to fund biotech Its efforts reflect a larger trend of states targeting bioscience as a source of future jobs and revenue. Overall, at least 41 states have instituted initiatives in recent years to attract new life-sciences companies, according to research conducted by Columbus, Ohio-based nonprofit organization Battelle Memorial Institute




Click here for reuse options!
Copyright 2002 Biotechblog

Biotech stocks show indication of rebounding

Biotech stocks show indication of rebounding Biotechnology stocks, down sharply since late last year because of a raft of bad news, appeared to begin a comeback last week as clinical trials results were leaked in advance of a major scientific meeting.




Click here for reuse options!
Copyright 2002 Biotechblog

Chinese cloning control required

Chinese cloning control required Strict ethical guidelines are needed in China to calm public fears about new cell technologies such as cloning, one of the country’s leading scientists has said.




Click here for reuse options!
Copyright 2002 Biotechblog

Veteran biotech investors offer tips from trenches

Veteran biotech investors offer tips from trenches These market-hardened biotech investors made three basic recommendations: be patient, take profit when you can, and don’t believe hype. Although this may sound like Investing 101, their lessons have the added credibility of being based on real life.




Click here for reuse options!
Copyright 2002 Biotechblog

Genome Group Rips Human Cloning

Genome Group Rips Human Cloning Scientists at the Human Genome Organization have condemned plans for human cloning, saying it raises deep concerns over moral issues and arguing that the technology was far from mature and its side effects were unknown.




Click here for reuse options!
Copyright 2002 Biotechblog

As Pipelines Wither, Pharma and FDA Explore Whether Microarrays are Ready for Primetime

As Pipelines Wither, Pharma and FDA Explore Whether Microarrays are Ready for Primetime When can the pharmaceutical industry start trusting the technology? When should it make the leap from investigative, experimental technique to industry standard? And should the FDA start using microarray data to make critical decisions about the safety and efficacy of new drugs?




Click here for reuse options!
Copyright 2002 Biotechblog

Research 'leak' hits Genentech

Research ‘leak’ hits Genentech Genentech’s shares dropped 12.5 per cent after details of the biotechnology company’s research abstracts for next month’s American Society of Clinical Oncology appeared to have been leaked.




Click here for reuse options!
Copyright 2002 Biotechblog

Research ‘leak’ hits Genentech

Research ‘leak’ hits Genentech Genentech’s shares dropped 12.5 per cent after details of the biotechnology company’s research abstracts for next month’s American Society of Clinical Oncology appeared to have been leaked.




Click here for reuse options!
Copyright 2002 Biotechblog

As Tony White Reads Resumes, Industry Buzzes Around Core Four

As Tony White Reads Resumes, Industry Buzzes Around Core Four It’s been two-and-a-half months since J. Craig walked away from Celera and Applera chief Tony White is still skimming resumes. Though Celera has been characteristically mum about potential prospects or their status, an initial shortlist of four likely candidates compiled by GenomeWeb from interviews with […]




Click here for reuse options!
Copyright 2002 Biotechblog

%d bloggers like this: